Lulu Chu

Lulu Chu

Takeda Pharmaceutical Company Limited - Osaka / Japan
Engineering & Technology / Biomedical Engineering
AD Scientific Index ID: 4507621
武田薬品工業株式会社
person_outline Lulu Chu's MOST POPULAR ARTICLES
1-) Radiation and PD-(L) 1 treatment combinations: immune response and dose optimization via a predictive systems modelY Kosinsky, SJ Dovedi, K Peskov, V Voronova, L Chu, H Tomkinson, ...Journal for immunotherapy of cancer 6 (1), 1-15, 2018692018
2-) Evaluation of renal and cardiovascular protection mechanisms of SGLT2 inhibitors: model-based analysis of clinical dataKM Hallow, PJ Greasley, G Helmlinger, L Chu, HJ Heerspink, DW BoultonAmerican Journal of Physiology-Renal Physiology 315 (5), F1295-F1306, 2018412018
3-) Quantitative systems pharmacology: an exemplar model‐building workflow with applications in cardiovascular, metabolic, and oncology drug developmentG Helmlinger, V Sokolov, K Peskov, KM Hallow, Y Kosinsky, V Voronova, ...CPT: pharmacometrics & systems pharmacology 8 (6), 380-395, 2019282019
4-) Chimeric antigen receptor T cell therapies: a review of cellular kinetic‐pharmacodynamic modeling approachesA Chaudhury, X Zhu, L Chu, A Goliaei, CH June, JD Kearns, AM SteinThe Journal of Clinical Pharmacology 60, S147-S159, 2020492020
5-) Quantitative mechanistic modeling in support of pharmacological therapeutics development in immuno-oncologyK Peskov, I Azarov, L Chu, V Voronova, Y Kosinsky, G HelmlingerFrontiers in immunology 10, 924, 2019372019